Study of Genetic Variants and Prostate Cancer Risk
Author Information
Author(s): Lindstrom Sara, Schumacher Fredrick, Siddiq Afshan, Travis Ruth C., Campa Daniele, Berndt Sonja I., Diver W. Ryan, Severi Gianluca, Allen Naomi, Andriole Gerald, Bueno-de-Mesquita Bas, Chanock Stephen J., Crawford David, Gaziano J. Michael, Giles Graham G., Giovannucci Edward, Guo Carolyn, Haiman Christopher A., Hayes Richard B., Halkjaer Jytte, Hunter David J., Johansson Mattias, Kaaks Rudolf, Kolonel Laurence N., Navarro Carmen, Riboli Elio, Sacerdote Carlotta, Stampfer Meir, Stram Daniel O., Thun Michael J., Trichopoulos Dimitrios, Virtamo Jarmo, Weinstein Stephanie J., Yeager Meredith, Henderson Brian, Ma Jing, Le Marchand Loic, Albanes Demetrius, Kraft Peter
Primary Institution: Harvard School of Public Health
Hypothesis
Do genetic variants associated with prostate cancer risk interact with environmental factors and vary by disease aggressiveness?
Conclusion
The study found that while 36 out of 39 SNPs were associated with prostate cancer risk, there was little evidence of interaction with environmental factors or variation by disease aggressiveness.
Supporting Evidence
- 36 out of 39 SNPs were replicated in the study.
- Two SNPs near KLK3 showed differential association with Gleason grade.
- Family history of prostate cancer was strongly associated with risk.
- Obesity was inversely associated with prostate cancer risk in non-aggressive cases.
- Alcohol consumption above 30 g/day was associated with increased prostate cancer risk.
Takeaway
Scientists looked at genes that might make people more likely to get prostate cancer and found some links, but they didn't see much difference based on other factors like lifestyle.
Methodology
The study genotyped 39 SNPs in 10,501 prostate cancer cases and 10,831 controls and analyzed associations with clinical factors and environmental risk factors.
Potential Biases
Potential misclassification in environmental exposure data.
Limitations
The study was limited to individuals of European ancestry and may not generalize to other populations.
Participant Demographics
The study included 10,501 prostate cancer cases and 10,831 controls, primarily of European ancestry.
Statistical Information
P-Value
p<0.0001 for significant SNP associations
Confidence Interval
95% CI: 0.77–0.83 for strongest association
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website